Assessment of biomarkers of exposure and potential harm, and physiological and subjective health measures in exclusive users of nicotine pouches and current, former and never smokers
Individual Clinical
Biomarkers
Biomarkers Of Exposure
Azzopardi (2023)
Harmful and potentially harmful constituents (HPHCs) in two novel nicotine pouch products in comparison with regular smokeless tobacco products and pharmaceutical nicotine replacement therapy products (NRTs)
Individual Clinical
Safety
Adverse Effects
Back (2023)
association between use of electronic vaping products and insufficient sleep among adolescents: Findings from the 2017 and 2019 YRBS.
Individual Clinical
Safety
Adverse Effects
Baiden (2023)
Use of electronic cigarettes leads to significant beta2-nicotinic acetylcholine receptor occupancy: Evidence from a PET imaging study.
Individual Clinical
Biomarkers
Biomarkers Of Exposure
Baldassarri (2018)
how harmful are e-cigarettes to the head and neck cells?
Individual Clinical
Safety
Adverse Effects
Baniulyte (2022)
Do e-cigarettes have a part to play in peri-implant diseases?
Individual Clinical
Safety
Adverse Effects
Baniulyte (2023)
“Technophilia”: a new risk factor for electronic cigarette use among early adolescents?
Individual Clinical
Safety
Adverse Effects
Barrientos-Gutierrez (2019)
Systematic Review of Electronic Cigarette Use (Vaping) and Mental health Comorbidity among adolescents and Young adults.
Individual Clinical
Safety
Adverse Effects
Becker (2021)
Characterization of Ad Libitum Use Behavior of On! Nicotine Pouches
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Becker (2023)
Pod-based e-cigarettes versus combustible cigarettes: The impact on peripheral and cerebral vascular function and subjective experiences.
Individual Clinical
Safety
Adverse Effects
Ben Taleb (2023)